Language Select
Varian Logo

INVESTOR RELATIONS

 

Subscribe
Investor Meeting at ASTRO

Monday, September 16, 2019
2:00pm CT
Listen to Webcast
Presentation

Varian Updates Investors on Proposed Reimbursement Changes

Thursday, August 8, 2019

Presentation

Third Quarter FY2019 Earnings Results Conference Call

Wednesday, July 24, 2019
1:30pm PDT

Listen to Webcast
Presentation
 

Investor Information

Recent News
Oct 8, 2019
Varian Highlights Interventional Oncology Solutions at CIO Symposium

Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional...

Sep 23, 2019
Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components

Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section...

Sep 16, 2019
Varian Names Chief Medical Officer for Interventional Oncology

Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September...

More news >


Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR
  • Follow Us

© 1999-2019 Varian Medical Systems, Inc.
All Rights reserved.

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo